A detailed history of Assetmark, Inc transactions in Embecta Corp. stock. As of the latest transaction made, Assetmark, Inc holds 2 shares of EMBC stock, worth $29. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$29
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.13 - $14.6 $496 - $715
-49 Reduced 96.08%
2 $0
Q1 2024

May 06, 2024

BUY
$12.35 - $19.33 $543 - $850
44 Added 628.57%
51 $0
Q4 2023

Feb 09, 2024

SELL
$12.87 - $19.09 $12 - $19
-1 Reduced 12.5%
7 $0
Q3 2022

Nov 01, 2022

SELL
$24.0 - $33.42 $24 - $33
-1 Reduced 11.11%
8 $0
Q2 2022

Aug 03, 2022

BUY
$24.78 - $33.36 $223 - $300
9 New
9 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $859M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.